Stocks Explorer
Stocks
Sectors
Search
I-Mab(IMAB) News
Profile
Chart
News
Analysis
Holders
IMAB price today
by TradingView
Date
Title
Nov 2
Felzartamab Granted Breakthrough Therapy Designation by U.S. Food and Drug Administration (FDA) for Primary Membranous Nephropathy (PMN)
‹ Prev
Page
of 2
Next ›